Glioma targeting peptide modified apoferritin nanocage

Therapeutic outcome for the treatment of glioma was often limited due to the non-targeted nature of drugs and the physiological barriers, including the blood-brain barrier (BBB) and the blood-brain tumor barrier (BBTB). An ideal glioma-targeted delivery system must be sufficiently potent to cross th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Meifang, Wang, Yuli, Zhang, Ligang, Liang, Meng, Fu, Shiyao, Cui, Lin, Yang, Meiyan, Gong, Wei, Li, Zhiping, Yu, Lian, Xie, Xiangyang, Yang, Chunrong, Yang, Yang, Gao, Chunsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058491/
https://www.ncbi.nlm.nih.gov/pubmed/29726297
http://dx.doi.org/10.1080/10717544.2018.1464082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058491/
https://www.ncbi.nlm.nih.gov/pubmed/29726297
http://dx.doi.org/10.1080/10717544.2018.1464082

Ejemplares similares